MML Investors Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,954
| Closed | -$726K | – | 2023 |
|
|
2021
Q2 | $726K | Sell |
3,954
-9,583
| -71% | -$1.76M | 0.01% | 1150 |
|
|
2021
Q1 | $2.07M | Sell |
13,537
-8,260
| -38% | -$1.26M | 0.02% | 646 |
|
|
2020
Q4 | $3.41M | Sell |
21,797
-920
| -4% | -$144K | 0.04% | 409 |
|
|
2020
Q3 | $2.6M | Buy |
22,717
+340
| +2% | +$38.9K | 0.03% | 440 |
|
|
2020
Q2 | $2.51M | Sell |
22,377
-3,342
| -13% | -$375K | 0.03% | 421 |
|
|
2020
Q1 | $2.31M | Buy |
25,719
+9,181
| +56% | +$824K | 0.04% | 378 |
|
|
2019
Q4 | $1.79M | Buy |
16,538
+4,515
| +38% | +$488K | 0.03% | 517 |
|
|
2019
Q3 | $1.18M | Buy |
12,023
+3,439
| +40% | +$337K | 0.02% | 615 |
|
|
2019
Q2 | $1.12M | Buy |
8,584
+1,392
| +19% | +$182K | 0.02% | 676 |
|
|
2019
Q1 | $972K | Buy |
7,192
+1,184
| +20% | +$160K | 0.02% | 710 |
|
|
2018
Q4 | $585K | Buy |
6,008
+666
| +12% | +$64.8K | 0.01% | 835 |
|
|
2018
Q3 | $743K | Buy |
5,342
+583
| +12% | +$81.1K | 0.01% | 802 |
|
|
2018
Q2 | $591K | Buy |
4,759
+245
| +5% | +$30.4K | 0.01% | 774 |
|
|
2018
Q1 | $503K | Sell |
4,514
-404
| -8% | -$45K | 0.01% | 844 |
|
|
2017
Q4 | $588K | Buy |
4,918
+1,230
| +33% | +$147K | 0.01% | 758 |
|
|
2017
Q3 | $517K | Sell |
3,688
-875
| -19% | -$123K | 0.01% | 771 |
|
|
2017
Q2 | $555K | Buy |
4,563
+192
| +4% | +$23.4K | 0.01% | 727 |
|
|
2017
Q1 | $530K | Buy |
+4,371
| New | +$530K | 0.01% | 433 |
|